Photocatalytic degradation kinetics, mechanism and ecotoxicity assessment of tramadol metabolites in aqueous TiO2 suspensions

Synthesis and comparison of three photocatalysts for degrading tramadol as an analgesic and widely used drug in water samples

Tramadol is an analgesic drug that is mainly excreted in the urine. The entry of Tramadol into water samples causes their biological contamination. Therefore, three catalysts such as bismuth ferrite, cobalt-doped bismuth ferrite, and a magnetized Keggin type of polyoxometalate (α-Fe₂O₃@phosphotungstic acid), were synthesized as photocatalysts to degrade Tramadol in water samples. The morphology and properties of the prepared photocatalysts were evaluated using several techniques. Effects of several factors, including tramadol concentration, pH, hydrogen peroxide concentration, and photocatalyst amount, were studied and optimized by a design experiment procedure based on Box-Behnken design for reducing the number of experiments and cost and investigating the interactions between factors in the photocatalytic degradation process of Tramadol. These factors were optimized for each prepared photocatalyst individually. Under the optimum conditions, the percentages of tramadol degradation and kinetics of the degradation process were evaluated in the presence of each photocatalyst. The tramadol degradation percentages using bismuth ferrite, cobalt-doped bismuth ferrite, and α-Fe₂O₃ @phosphotungstic acid were 81.10% for 120 min, 90.63% for 80 min, and 91.32% for 80 min, respectively. The rate constants of tramadol degradation were 0.0145, 0.0329, and 0.0312 min^-1 for bismuth ferrite, cobalt-doped bismuth ferrite, and α-Fe₂O₃ @phosphotungstic acid, respectively. The results indicated the highest percentage of tramadol degradation and rate of the degradation process were obtained using α-Fe₂O₃ @phosphotungstic acid and cobalt-doped bismuth ferrite, respectively.

Photocatalytic Degradation of Pharmaceutical Amisulpride Using g-C3N4 Catalyst and UV-A Irradiation

In the present study, the photocatalytic degradation of amisulpride using g-C3N4 catalyst under UV-A irradiation was investigated. The photocatalytic process was evaluated in terms of its effectiveness to remove amisulpride from ultrapure and real municipal wastewater. High removal percentages were achieved in both aqueous matrices. However, a slower degradation rate was observed using wastewater as matrix that could be attributed to its complex chemical composition. The transformation products (TPs) were identified with liquid chromatography–mass spectrometry (LC–MS) in both ultrapure and real municipal wastewater. Based on the identified TPs, the photocatalytic degradation pathways of amisulpride are proposed which include mainly oxidation, dealkylation, and cleavage of the methoxy group. Moreover, the contribution of reactive species to the degradation mechanism was studied using well-documented scavengers, and the significant role of h+ and O2•− in the reaction mechanism was proved. The evolution of ecotoxicity was also estimated using microalgae Chlorococcum sp. and Dunaliella tertiolecta. Low toxicity was observed during the overall process without the formation of toxic TPs when ultrapure water was used as matrix. In the case of real municipal wastewater, an increased toxicity was observed at the beginning of the process which is attributed to the composition of the matrix. The application of heterogeneous photocatalysis reduced the toxicity, and almost complete detoxification was achieved at the end of the process. Our results are in accordance with literature data that reported that heterogeneous photocatalysis is effective for the removal of amisulpride from aqueous matrices.

The overall assessment of simultaneous photocatalytic degradation of Cimetidine and Amisulpride by using chemical and genotoxicological approaches

Pharmaceutical Active Compounds (PhACs) are of particular interest among the emerging contaminants detected in the aquatic environment. Commonly, PhACs exist as complex mixtures in aquatic systems, causing potential adverse effects to the environment and human health than those of individual compounds. Based on the increasing interest in the contamination of water resources by PhACs, the photocatalytic degradation of Cimetidine and Amisulpride as a mixture in combination with their toxic and genotoxic effects before and after the treatment were evaluated for the first time. The toxic, genotoxic and cytotoxic effects were investigated using the Trypan Blue Exclusion Test and the Cytokinesis Block MicroNucleus (CBMN) assay in cultured human lymphocytes. The photocatalytic degradation of the PhACs was studied in ultrapure water and environmentally relevant matrices using UV-A and visible (Vis) irradiation and C-TiO₂ (TiO₂ Kronos vlp 7000) as photocatalyst. High removal percentages were observed for both compounds under UV-A and Vis irradiation in ultrapure water. In lake and drinking water a slower degradation rate was shown that could be attributed to the complex composition of these matrices. Scavenging experiments highlighted the significant role of h⁺ and O₂^●- in the degradation mechanisms under both irradiation sources. Oxidation, dealkylation and deamination were the main degradation pathways. Regarding the individual compounds, Amisulpride was found to be more cytotoxic than Cimetidine. No significant differences of the genotoxic effects during the treatment were observed. However, a slight increase in cytotoxicity was observed at the first stages of the process. At the end of the process under both UV-A and Vis light, non-significant cytotoxic/toxic effects were observed. Based on the results, heterogeneous photocatalysis can be considered as an effective process for the treatment of complex mixtures without the formation of harmful transformation products.

Determination of dextromethorphan and dextrorphan solar photo-transformation products by LC/Q-TOF-MS: Laboratory scale experiments and real water samples analysis

This work discusses the identification of the transformation products (TPs) generated during the photolytic degradation of dextromethorphan (DXM) and its metabolite dextrorphan (DXO), under simulated solar radiation in aqueous solutions (Milli-Q water and river water) in order to determinate its behavior into the aquatic environment. Tentative identification of the TPs was performed by liquid chromatography/quadrupole time-of-flight mass spectrometry (LC/QTOF-MS), following a suspect screening approach. The use of high resolution-mass spectrometry (HRMS) allowed the tentative identification of DXM and DXO photoproducts based on the structure proposed by an in silico software, the accurate mass measurement, the MS/MS fragmentation pattern and the molecular formula finding. A total of 19 TPs were found to match some of the accurate masses included in a suspect list, and they were all tentatively identified by their characteristic MS-MS fragments. Most of the TPs identified showed a minor modified molecular structure like the introduction of hydroxyl groups, or demethylation. The time-evolution of precursors and TPs were monitored throughout the experiments, and degradation kinetics were presented for each analyte. Finally, the occurrence of DXM, DXO, and their tentatively proposed photodegradation TPs was evaluated in both surface and wastewater. In all real matrices, the results showed that the highest concentration was detected for DXO, followed by TP-244 (N-desmethyldextrorphan) and DXM.

Assessing the human risk and the environmental fate of pharmaceutical Tramadol

Tramadol (TRA) is a widely used human pharmaceutical and a well-established emerging pollutant and its potential genotoxic and cytotoxic effects on humans as well as its fate in aqueous systems demand full investigation. The present study is a multidisciplinary approach and provides important insights on the potential risks of Tramadol on humans accompanied by its photolytic transformation under simulated solar irradiation. The present study revealed that Tramadol can induce genotoxic and cytotoxic effects under the specific experimental conditions, significantly depended on the tested concentration. In addition, the photolytic transformation of Tramadol was investigated in detail under simulated solar irradiation in two different water matrices: ultrapure water (UW) and treated wastewater (WW). Differences in the degradation rates were observed between UW and WW, being slower in WW. The results showed that more than 70% of Tramadol was removed after 240 min in UW ([TRA] = 10 mg L^-1, I = 500 W m^-2). After this period, TOC removal was found to be about 40%. Transformation of N atoms into NO₃^- and NH₄⁺ followed a similar trend reaching up to 38% release. Τramadol degraded mainly by HO radicals and ¹O₂ through a self-sensitizing process while direct photolysis was also significant. Hydroxylation, demethylation and N-oxidation of the parent compound were found to be the main degradation pathways confirming the important role of HO and ¹O₂ in the photolytic process. Toxicity measurements showed a noticeable increase of the inhibition for Vibrio fischeri at the first stages which coincide with the formation of the major TPs.

Photocatalytic degradation of cyclophosphamide and ifosfamide: Effects of wastewater matrix, transformation products and in silico toxicity prediction

Antineoplastic drugs have been identified in surface water and effluents from wastewater treatment and, once in the environment, may be harmful to aquatic organisms, as these compounds are possibly mutagenic, genotoxic, cytotoxic, carcinogenic and teratogenic. This work investigated the photodegradation of cyclophosphamide (CP) and ifosfamide (IF) using ruthenium doped titanate nanowires (Ru-TNW) in distilled water (DW) and in wastewater (WW) from secondary wastewater treatment, under UV-Vis radiation. The results indicated that Ru-TNW showed photocatalytic activity for the two cytotoxic drugs with the half-life (t_1/2) of 15.1 min for CP and 12.9 min for IF in WW. Four CP transformation products (TPs) and six IF TPs from the photodegradation process are here reported. These TPs were elucidated by high-resolution mass spectrometry. For both pollutants, the results showed different time profiles for the TPs when WW and DW were used as matrix. Overall, in the WW there was a higher production of TPs and two of them were detected only in this matrix. In other words, environmental matrices may produce different TPs. Degradation pathways were proposed and both drugs bear similarities. Additionally, in silico toxicity were performed by quantitative structure-activity relationship models. The predictions indicated that the TPs, with the exception of one IF TP, presented high mutagenic potential.

Disinfection by-Products and Ecotoxic Risk Associated with Hypochlorite Treatment of Tramadol

In recent years, many studies have highlighted the consistent finding of tramadol (TRA) in the effluents from wastewater treatment plants (WTPs) and also in some rivers and lakes in both Europe and North America, suggesting that TRA is removed by no more than 36% by specific disinfection treatments. The extensive use of this drug has led to environmental pollution of both water and soil, up to its detection in growing plants. In order to expand the knowledge about TRA toxicity as well as the nature of its disinfection by-products (DBPs), a simulation of the waste treatment chlorination step has been reported herein. In particular, we found seven new by-products, that together with TRA, have been assayed on different living organisms (Aliivibrio fischeri, Raphidocelis subcapitata and Daphnia magna), to test their acute and chronic toxicity. The results reported that TRA may be classified as a harmful compound to some aquatic organisms whereas its chlorinated product mixture showed no effects on any of the organisms tested. All data suggest however that TRA chlorination treatment produces a variety of DBPs which can be more harmful than TRA and a risk for the aquatic environment and human health.

Potential risks from UV/H2O2 oxidation and UV photocatalysis: A review of toxic, assimilable, and sensory-unpleasant transformation products

UV based advanced oxidation processes (UV-AOPs) that efficiently eliminate organic pollutants during water treatment have been the subject of numerous investigations. Most organic pollutants are not completely mineralized during UV-AOPs but are partially oxidized into transformation products (TPs), thereby adding complexity to the treated water and posing risks to humans, ecological systems, and the environment. While the degradation kinetics and mechanisms of pollutants have been widely documented, there is little information about the risks associated with TPs. In this review, we have collated recent knowledge about the harmful TPs that are generated in UV/H₂O₂ and UV photocatalysis, two UV-AOPs that have been studied extensively. Toxic and assimilable TPs were ubiquitously observed in more than 80% of UV-AOPs of organic pollutants, of which the toxicity and assimilability levels changed with variations in the reaction conditions, such as the UV fluence and oxidant dosage. Previous studies and modeling assessments showed that toxic and assimilable TPs may be generated during hydroxylation, dealkylation, decarboxylation, and deamination. Among various reactions, TPs generated from dealkylation and decarboxylation were generally less and more toxic than the parent pollutants, respectively; TPs generated from decarboxylation and deamination were generally less and more assimilable than the parent pollutants, respectively. There is also potential concern about the sensory-unpleasant TPs generated by oxidations and subsequent metabolism of microorganisms. In this overview, we stress the need to include both the concentrations of organic pollutants and the evaluations of the risks from TPs for the quality assessments of the water treated by UV-AOPs.

Advanced oxidation process-mediated removal of pharmaceuticals from water: A review

Pharmaceuticals, which are frequently detected in natural and wastewater bodies as well as drinking water have attracted considerable attention, because they do not readily biodegrade and may persist and remain toxic. As a result, pharmaceutical residues pose on-going and potential health and environmental risks. To tackle these emerging contaminants, advanced oxidation processes (AOPs) such as photo-Fenton, sonolysis, electrochemical oxidation, radiation and ozonation etc. have been applied to remove pharmaceuticals. These processes utilize the high reactivity of hydroxyl radicals to progressively oxidize organic compounds to innocuous products. This review provides an overview of the findings from recent studies, which have applied AOPs to degrade pharmaceutical compounds. Included is a discussion that links various factors of TiO₂-mediated photocatalytic treatment to its effectiveness in degrading pharmaceutical residues. This review furthermore highlights the success of AOPs in the removal of pharmaceuticals from different water matrices and recommendations for future studies are outlined.

Vibrio fischeri bioluminescence inhibition assay for ecotoxicity assessment: A review

Vibrio fischeri bioluminescence inhibition bioassay (VFBIA) has been widely applied for the monitoring of toxicity on account of multiple advantages encompassing shorter test duration, sensitive, cost-effective and ease of operation. Moreover, this bioassay found to be equally applicable to all types of matrices (organic & inorganic compounds, metals, wastewater, river water, sewage sludge, landfill leachate, herbicides, treated wastewater etc.) for toxicity monitoring. This review highlights the apparent significance of Vibrio fischeri bioluminescence inhibition assay for ecotoxicological screening and evaluation of diverse chemical substances toxicity profile. The biochemical and genetic basis of the bioluminescence assay and its regulatory mechanism have been concisely discussed. The basic test protocol with ongoing improvements, widespread applications, typical advantages and probable limitations of the assay have been overviewed. The sensitivity of VFBIA and toxicity bioassays has also been compared.

Degradation of venlafaxine using TiO2/UV process: Kinetic studies, RSM optimization, identification of transformation products and toxicity evaluation

The photochemical degradation of the antidepressant drug venlafaxine (VNF) by UV/TiO₂ process was investigated in the present study. Prescreening experiments were conducted to study the effects of main parameters affecting the photocatalytic process. In addition, the effects and interactions of most influenced parameters were evaluated and optimized by using a central composite design model and a response surface methodology. Results indicated that VNF was quickly removed in all the irradiation experiments and its degradation was mainly affected by the studied variables (catalyst dose, initial VNF concentration and pH), as well as their interaction effects. Parallel to kinetic studies, the transformation products (TPs) generated during the treatment was investigated using LC coupled to low and high resolution mass spectrometry. Based on identification of the main TPs, tentative transformation pathways were proposed, including hydroxylation, demethylation and dehydration as major transformation routes. Τhe potential risk of VNF and its TPs to aqueous organisms was also investigated using Microtox bioassay before and during the processes. The obtained results showed an increment in the acute toxicity in the first stages and a continuously decreasing after then to very low values reached within 240min of the photocatalytic treatment, demonstrating that UV/TiO₂ can lead to the elimination of parent compound and the detoxification of the solution.